Nuzenio

Endpoints

Endpoints news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Is China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more - Endpoints NewsEndpoints News · Sat, 08 Aug 2026 10:00:00 GMTCoinMarketCap Expands Its Pro API With Real-World Asset Data Endpoints - HackerNoonHackerNoon · Fri, 07 Aug 2026 22:00:50 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 16:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 15:08:00 GMTBioMarin axes $270M asset after missing phase 3 endpoint - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 13:10:41 GMTJennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 11:00:00 GMTReplimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 20:03:00 GMTExclusive: FDA outlines expedited IND pilot plans, seeking to pick up to 10 programs by year's end - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 19:17:43 GMT

Timeline

Sat, 08 Aug 2026 10:00:00 GMTIs China’s work ethic a ‘wake-up call’?; The megamerger that wasn’t; and more - Endpoints News
Fri, 07 Aug 2026 22:00:50 GMTCoinMarketCap Expands Its Pro API With Real-World Asset Data Endpoints - HackerNoon
Fri, 07 Aug 2026 16:08:00 GMTFDA to hold adcomm for Grail cancer test that failed in large, randomized trial - Endpoints News
Fri, 07 Aug 2026 15:08:00 GMTBioMarin discontinues rare disease drug; CSL and Arcturus split up - Endpoints News
Fri, 07 Aug 2026 13:10:41 GMTBioMarin axes $270M asset after missing phase 3 endpoint - Fierce Biotech
Fri, 07 Aug 2026 11:00:00 GMTJennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints News

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.CybersecurityCybersecurity stories explain incidents, vulnerabilities, affected organizations, user risk, patches, and accountability.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Endpoints.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.